Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetics of posttransplant diabetes mellitus.

The pharmacogenomics journal - 1 Jun 2017

Lancia P, Adam de Beaumais T, Jacqz-Aigrain E

Abstract excerpt

Many factors (physiological, pathological, environmental or genetic) are associated with variability in drug effect. Most patients respond to a standard treatment but the drug may be ineffective or toxic. In this review, we focused on genetic markers of posttransplant diabetes mellitus (PTDM) after renal transplantation, a frequent complication of immunosuppressive therapy and important risk factor of graft loss...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Glucose
Share to Diabetes Mellitus
Share to Immunosuppressive Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Insulin Secretion

Share to Kidney Transplantation

Share to Pharmacogenetics

Share to Pharmacogenomic Testing

Share to Pharmacogenomic Variants

Source

Identifiers

PMID: 28349930
DOI: 10.1038/tpj.2017.1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetics of posttransplant diabetes mellitus.PMID 28349930Read ↗

Posttransplantation diabetes mellitus (PTDM): pharmacological aspects and genetic predispositions.Semantic proximity Read ↗

Pharmacogenetics of post-transplant diabetes mellitus in children with renal transplantation treated with tacrolimus.Semantic proximity Read ↗

Pharmacogenomic Determinants of Post-Liver Transplant Diabetes Mellitus: A Systematic Review and In Silico Pharmacogenomic AnalysisSemantic proximity Read ↗

New challenges and promises in solid organ transplantation pharmacogenetics: the genetic variability of proteins involved in the pharmacodynamics of immunosuppressive drugs.Semantic proximity Read ↗

Genetic risk factors for post-transplantation diabetes mellitus in Chinese Han renal allograft recipients treated with tacrolimus.Semantic proximity Read ↗

Trends in Precision Medicine and Pharmacogenetics as an Adjuvant in Establishing a Correct Immunosuppressive Therapy for Kidney Transplant: An Up-to-Date Historical OverviewSemantic proximity Read ↗

Association between Genetic Polymorphisms and Risk of Kidney Posttransplant Diabetes Mellitus: A Systematic Review and Meta-Analysis.Semantic proximity Read ↗

Angiotensinogen polymorphisms and post-transplantation diabetes mellitus in Korean renal transplant subjects.Semantic proximity Read ↗

Analysis of common type 2 diabetes mellitus genetic risk factors in new-onset diabetes after transplantation in kidney transplant patients medicated with tacrolimus.Semantic proximity Read ↗

Prediction of diabetes mellitus development after kidney transplantation using patient-specific induced pluripotent stem cellsSemantic proximity Read ↗

Genetic prediction of renal transplant outcomeSemantic proximity Read ↗

Association of common type 2 diabetes risk gene variants and posttransplantation diabetes mellitus in renal allograft recipients in Korea.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.